Merit Financial Group, LLC Ptc Therapeutics, Inc. Transaction History
Merit Financial Group, LLC
- $6.49 Billion
- Q1 2025
A detailed history of Merit Financial Group, LLC transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Merit Financial Group, LLC holds 4,028 shares of PTCT stock, worth $199,506. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,028Holding current value
$199,506% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding PTCT
# of Institutions
264Shares Held
72.6MCall Options Held
179KPut Options Held
536K-
Vanguard Group Inc Valley Forge, PA9.18MShares$455 Million0.01% of portfolio
-
Black Rock Inc. New York, NY7.77MShares$385 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.39MShares$366 Million5.44% of portfolio
-
Armistice Capital, LLC New York, NY6.38MShares$316 Million4.07% of portfolio
-
Toronto Dominion Bank Toronto, Ontario, A63.29MShares$163 Million0.24% of portfolio
About PTC THERAPEUTICS, INC.
- Ticker PTCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,541,000
- Market Cap $3.54B
- Description
- PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...